SCHEMBL27588562

SCHEMBL27588562

NCc1c[c]ccc1Cc1ccc(O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABAT P80404 1/20 0.45
▸ ESR1 P03372 2/20 0.43
▸ ESR2 Q92731 2/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ TAAR1 Q96RJ0 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HTR3A P46098 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ BLM P54132 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ IDO1 P14902 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27606438 0.87 HRH3 (0.38) ABATTAAR1MAPTCA2
SCHEMBL27588547 0.84 CYP3A4 (0.45) ALDH1A1L3MBTL1TDP1CA2
SCHEMBL27606419 0.81 ENPP2 (0.51) TAAR1KDM4EKMT2ABLMMAPT
SCHEMBL27606516 0.81 ESR1 (0.45) ABATESR1ESR2KEAP1TAAR1
SCHEMBL27588531 0.79 LOXL2 (0.45) MAPT
SCHEMBL27606277 0.79 HRH3 (0.40) TAAR1ALDH1A1SLC6A2
SCHEMBL27588526 0.79 LTA4H (0.43) TAAR1ALDH1A1IDO1
SCHEMBL29041286 0.77 ESR1 (0.45) ABATESR1ESR2KEAP1CYP2C19
SCHEMBL27668934 0.77 PNMT (0.32) —
SCHEMBL28020723 0.76 TAAR1 (0.38) TAAR1ALDH1A1SLC6A2KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 — — CN disclosed
Send feedback